Dr. Minhong Yan joined BeiGene in September 2021 and is Vice President, Head of the BeiGene Institute. Prior to Joining BeiGene, he spent more than 20 years in the research division at Genentech, after obtaining his doctorate degree in molecular and cell biology from Case Western Reserve University. Dr. Yan brings rich expertise and experience in the biotech industry. He has initiated and led various drug programs for treating cancer, inflammation, and ocular diseases. He is the inventor of numerous U.S. patents.

Dr. Yan’s research interests span broad areas, including vascular biology, cancer immunology and antibody therapy. Intended to address fundamental questions with significant scientific and therapeutic ramifications, his research work has been published in high-impact journals including Nature, Science, Immunity, and Nature Immunology.